Source comparison
CJC-1295 No DAC & Ipamorelin Cycle: Protocol Comparison
Beginner / Observation 100mcg 1x daily (pre-sleep) 8 weeks Minimal receptor load, ideal for baseline IGF-1 tracking and tolerance assessment. Lowest risk of side effects Standard Research 100-150mcg 2x daily (morning, pre-sleep) 10-12 weeks Most common protoco
This comparison does not assign a generated winner or score.
- Beginner / Observation
- 100mcg
- 1x daily (pre-sleep)
- 8 weeks
- Minimal receptor load, ideal for baseline IGF-1 tracking and tolerance assessment. Lowest risk of side effects
- Standard Research
- 100-150mcg
- 2x daily (morning, pre-sleep)
- 10-12 weeks
- Most common protocol in published GH secretagogue research. Balances efficacy with manageable injection schedule
- Advanced Anabolic
- 150-200mcg
- 3x daily (morning, post-workout, pre-sleep)
- 8-10 weeks
- Maximum GH pulse frequency. Higher receptor saturation risk, requires 4-week washout minimum to prevent desensitization
- Recovery-Focused
- 2x daily (post-training, pre-sleep)
- 12 weeks
- Prioritizes sleep-phase GH elevation and tissue repair signaling. Lower total dose reduces lipolytic interference with caloric surplus